2 Ferrari Paddock Passes and VIP seats for the Italian Monza F1




2 Ferrari Paddock Passes and VIP seats for the Italian Monza F1
错过了?
欢迎您随时联系我们,好让我们帮助您实现梦想!
奖品
The two tickets are valid for Sunday September 6 2015 and include:
- 1 Parking pass at the Monza racetrack
- 2 Ferrari Hospitality passes (to enter the hospitality building)
- 2 Tribuna Passes
- 2 Paddock Passes
The funds raised from the auction will benefit the project "A Microarray Diagnostic platform for Duchenne Muscular Dystrophy". This new platform will allow a quicker and efficient diagosis and new studies on the patients suffering from muscular dystrophy.
Happy Charity!
原因
Founded in 1984 by the engineer Enzo Ferrari, in memory of his son Dino, supports and promotes scientific research through the “Centro Dino Ferrari”, in the field of neuromuscular, neurodegenerative and cerebrovascular diseases, also thanks to the help of generous donors.
The Associazione “Centro Dino Ferrari” ets , was recognized as an Ente Morale with legal status (D.P.R. 21 November 1984 n.1035), and was established within the Clinical Neurological Institute at the University of Milan, Fondazione I.R.C.C.S. Ca’ Granda Ospedale Maggiore Policlinico.
Piero Ferrari, Honorary President, continues the mission of his father Enzo, today, so that through the advancement and support of scientific research, it is possible to defeat devastating diseases such as: Muscular Dystrophy, Spinal Muscular Atrophy, Lateral Amiotrophic Sclerosis, Alzheimer’s disease, Parkinson’s Disease and Multiple Sclerosis.
"Centro Dino Ferrari" ets Association supports scientific research with particular regard to the development of new diagnostic and therapeutic methodologies. Since its inception, it has dedicated resources and energies to the promotional and financial support of the “Centro Dino Ferrari”.
It is also thanks to the contribution of the Association, through events and fundraising for research, that the "Centro Dino Ferrari" has achieved important scientific progress over the years. These results lead us to foresee further progress in the diagnosis, prevention and treatment of neuromuscular and neurodegenerative diseases for the near future.